Immunomodulatory effect of combination therapy with lovastatin and 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside alleviates neurodegeneration in experimental autoimmune encephalomyelitis. [electronic resource]
Producer: 20061024Description: 1012-25 p. digitalISSN:- 0002-9440
- AMP-Activated Protein Kinases
- Aminoimidazole Carboxamide -- administration & dosage
- Animals
- Dose-Response Relationship, Drug
- Drug Evaluation, Preclinical
- Drug Therapy, Combination
- Encephalomyelitis, Autoimmune, Experimental -- drug therapy
- Enzyme Activation -- drug effects
- Female
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- administration & dosage
- Hypoglycemic Agents -- administration & dosage
- Immunoglobulin G -- immunology
- Immunologic Factors -- administration & dosage
- Lovastatin -- administration & dosage
- Multienzyme Complexes -- immunology
- Multiple Sclerosis -- drug therapy
- Myelin Basic Protein -- immunology
- Protein Serine-Threonine Kinases -- immunology
- Rats
- Rats, Inbred Lew
- Ribonucleotides -- administration & dosage
- Th1 Cells -- immunology
- Th2 Cells -- immunology
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.